Insider · CIK 0002118509
Paul Glavine
Files at HELP (Helus Pharma Inc.). First filing Sep 9, 2026, latest Sep 11, 2026.
Paul Glavine files SEC Form 4 as officer and director at HELP (Helus Pharma Inc.). Since Sep 9, 2026, Paul Glavine has reported 4 open-market buys worth $4.7M and 0 open-market sells worth $0, the latest filed on Sep 11, 2026.
A track record needs three past buys with six months of prices behind them; Paul Glavine has 0, so none is measured yet.
The newest scored trade: bought $1.2M of HELP on Sep 8, 2026, filed Sep 11, 2026, scored 60 (notable). In the last 12 months: 4 buys worth $4.7M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HELP: Helus Pharma Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Helus Pharma Inc. | $1.2M 100,000 shares | +2% | - | |
| 60Notable | Helus Pharma Inc. | $1.2M 100,000 shares | +2% | - | |
| 53Moderate | Helus Pharma Inc. | $1.2M 100,000 shares | +2% | - | |
| 48Moderate | Helus Pharma Inc. | $1.0M 90,000 shares | +2% | - |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | HELP Helus Pharma Inc. | AGrant or award Common Shares | +248,000 | - | - | 4,750,191 | 12 d ago |
| Sep 8, 2026 | HELP Helus Pharma Inc. | POpen-market purchase Common Shares | +100,000 | $12.47 | $1.2M | 4,271,252 | 32 d ago |
| Sep 8, 2026 | HELP Helus Pharma Inc. | POpen-market purchase Common Shares | +100,000 | $12.47 | $1.2M | 4,271,252 | 32 d ago |
| Sep 3, 2026 | HELP Helus Pharma Inc. | POpen-market purchase Common Shares | +100,000 | $11.78 | $1.2M | 4,171,252 | 33 d ago |
| Aug 31, 2026 | HELP Helus Pharma Inc. | POpen-market purchase Common Shares | +90,000 | $11.59 | $1.0M | 4,071,252 | 34 d ago |
Questions about Paul Glavine
Answered from the filings on this page, as of the latest one.
Is Paul Glavine buying or selling?
In the last 12 months Paul Glavine reported 4 open-market buys worth $4.7M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $1.2M of HELP on Sep 8, 2026. Grants, option exercises and tax withholding are not counted.
How did Paul Glavine's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul Glavine has 0.
Where does Paul Glavine file Form 4?
Paul Glavine has filed Form 4 at HELP (Helus Pharma Inc.) as Chief Growth Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.